» Articles » PMID: 22705304

MiR-7 and MiR-218 Epigenetically Control Tumor Suppressor Genes RASSF1A and Claudin-6 by Targeting HoxB3 in Breast Cancer

Overview
Publisher Elsevier
Specialty Biochemistry
Date 2012 Jun 19
PMID 22705304
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Many microRNAs have been implicated as key regulators of cellular growth and differentiation and have been found to dysregulate proliferation in human tumors, including breast cancer. Cancer-linked microRNAs also alter the epigenetic landscape by way of DNA methylation and post-translational modifications of histones. Aberrations in Hox gene expression are important for oncogene or tumor suppressor during abnormal development and malignancy. Although recent studies suggest that HoxB3 is critical in breast cancer, the putative role(s) of microRNAs impinging on HoxB3 is not yet fully understood. In this study, we found that the expression levels of miR-7 and miR-218 were strongly and reversely associated with HoxB3 expression. Stable overexpression of miR-7 and miR-218 was accompanied by reactivation of tumor suppressor genes including RASSF1A and Claudin-6 by means of epigenetic switches in DNA methylation and histone modification, giving rise to inhibition of the cell cycle and clone formation of breast cancer cells. The current study provides a novel link between overexpression of collinear Hox genes and multiple microRNAs in human breast malignancy.

Citing Articles

Non-Coding RNAs in Breast Cancer: Diagnostic and Therapeutic Implications.

Benacka R, Szaboova D, Gulasova Z, Hertelyova Z Int J Mol Sci. 2025; 26(1.

PMID: 39795985 PMC: 11719911. DOI: 10.3390/ijms26010127.


Large-Scale Isolation of Milk Exosomes for Skincare.

Wu X, Shen J, Zhong Y, Zhao X, Zhou W, Gao P Pharmaceutics. 2024; 16(7).

PMID: 39065627 PMC: 11279399. DOI: 10.3390/pharmaceutics16070930.


Prospects of microRNAs as therapeutic biomarkers in non-small cell lung cancer.

Samson J, Parvathi V Med Oncol. 2023; 40(12):345.

PMID: 37922117 DOI: 10.1007/s12032-023-02212-5.


Tumor suppressor miR-218 directly targets epidermal growth factor receptor (EGFR) expression in triple-negative breast cancer, sensitizing cells to irradiation.

Wischmann F, Troschel F, Frankenberg M, Kemper B, Vijaya Kumar A, Sicking M J Cancer Res Clin Oncol. 2023; 149(11):8455-8465.

PMID: 37088795 PMC: 10374822. DOI: 10.1007/s00432-023-04750-x.


MicroRNAs: A Link between Mammary Gland Development and Breast Cancer.

Wu D, Thompson L, Comelli E Int J Mol Sci. 2022; 23(24).

PMID: 36555616 PMC: 9786715. DOI: 10.3390/ijms232415978.